(Total Views: 520)
Posted On: 04/03/2025 9:22:55 AM
Post# of 153987
I guess now it's official.
Leronlimab Gets FDA Nod for Phase 2 Microsatellite-Stable CRC Trial
The FDA granted clearance for the start of a phase 2 study (NCT06699835) evaluating leronlimab in patients with relapsed/refractory microsatellite stable metastatic colorectal cancer on March 27, 2025.
https://www.targetedonc.com/view/leronlimab-g...-crc-trial
Leronlimab Gets FDA Nod for Phase 2 Microsatellite-Stable CRC Trial
The FDA granted clearance for the start of a phase 2 study (NCT06699835) evaluating leronlimab in patients with relapsed/refractory microsatellite stable metastatic colorectal cancer on March 27, 2025.
https://www.targetedonc.com/view/leronlimab-g...-crc-trial
(3)
(0)
